Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.optm.2008.01.013 | DOI Listing |
Neurocrit Care
April 2022
Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Background: Delirium screening instruments (DSIs) should be used to detect delirium, but they only show moderate sensitivity in patients with neurocritical illness. We explored whether, for these patients, DSI validity is impacted by patient-specific covariates.
Methods: Data were prospectively collected in a single-center quality improvement project.
Neurology
February 2004
Institute of Neurology, University College London, UK.
Background: Triptans are widely used to treat migraine but have been associated with stroke, myocardial infarction (MI), and ischemic heart disease (IHD) in case reports.
Objective: To estimate the incidence of stroke, cardiovascular events, and death in a migraine cohort, stratified by triptan prescription, and investigate whether the risk of these events was increased in those treated with triptans.
Methods: Migraine patients and matched nonmigraine control subjects were identified from the General Practice Research Database.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!